Subarachnoid Hemorrhage
Conditions
Keywords
Cognitive function, Quality of Life
Brief summary
The current study is a continuation of the study Effect of early rehabilitation in patients with acute aSAH which was approved by the Regional Committee for Medical Research Ethics, South-East Norway, archive number 2011/2189, Clinical Trials number 0925-0586 (Clinical Trials gov. identifier NCT01656317). The original study was a prospective, controlled, interventional study comprising patients managed at the neuro-intermediate ward following repair of a ruptured intracranial aneurysm in 2011-2012. 157 patients signed the informed consent form and were included in the study. Patients were assessed in the acute phase, as well as a 3 and 12 months post ictus. The main research goal of the present study will be to assess physical, cognitive and emotional function 5 and 10 years after aSAH in the 2011-2012 population. In addition we will also describe quality of life and work-status along with the time-course of recovery from the acute sage after aSAH to the chronic phase.
Interventions
BEHAVIORALClinical follow-up
All included patients will have a clinical follow-up consisting of: 1. A medical examination 2. Quality of life questionnaires 3. Neuropsychological test All instruments have been translated into Norwegian and validated and tested in clinical practice.
Sponsors
Oslo University Hospital
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No
Inclusion criteria
* Patients with aSAH treated at Oslo University Hospital in 2011-2012 * Only patients with signed informed consent form and thereby included the project Effect of early rehabilitation in patients with acute subarachnoid hemorrhage (Regional Committee for Medical Research Ethics, South-East Norway, archive number 2011/2189, Clinical Trials number 0925-0586, Clinical Trials gov. identifier NCT01656317) will be asked to participate.
Exclusion criteria
* Patients with aSAH treated at Oslo University Hospital in 2011-2012 who did not sign an informed consent form in the project Effect of early rehabilitation in patients with acute subarachnoid hemorrhage (Regional Committee for Medical Research Ethics, South-East Norway, archive number 2011/2189, Clinical Trials number 0925-0586, Clinical Trials gov. identifier NCT01656317)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| The Rivermead Post Concussion Symptom Questionnaire (RPQ) | Patients with an aSAH in 2011 will have their 5 years assessment in 2016 and 10 year assessment in 2021. Patients with an aSAH in 2012 will have their 5 year assessment in 2017 and 10 year assessment in 2022 | Questionnaire |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Short Form Health Survey (SF-36) | Patients with an aSAH in 2011 will have their 5 years assessment in 2016 and 10 year assessment in 2021. Patients with an aSAH in 2012 will have their 5 year assessment in 2017 and 10 year assessment in 2022 | Questionnaire |
| Fatigue Severity Scale (FSS) | Patients with an aSAH in 2011 will have their 5 years assessment in 2016 and 10 year assessment in 2021. Patients with an aSAH in 2012 will have their 5 year assessment in 2017 and 10 year assessment in 2022 | Questionnaire |
| Mental Fatigue Scale (MFS) | Patients with an aSAH in 2011 will have their 5 years assessment in 2016 and 10 year assessment in 2021. Patients with an aSAH in 2012 will have their 5 year assessment in 2017 and 10 year assessment in 2022 | Questionnaire |
| California Verbal Learning Test (CVLT) | Patients with an aSAH in 2011 will have their 5 years assessment in 2016 and 10 year assessment in 2021. Patients with an aSAH in 2012 will have their 5 year assessment in 2017 and 10 year assessment in 2022 | Test of verbal learning and memory |
| Behavioral Rating Inventory of Executive Function- Adult version (BRIEF-A) | Patients with an aSAH in 2011 will have their 5 years assessment in 2016 and 10 year assessment in 2021. Patients with an aSAH in 2012 will have their 5 year assessment in 2017 and 10 year assessment in 2022 | Questionnaire |
| Digit span, Wechsler Adult Intelligence Scale-IV | Patients with an aSAH in 2011 will have their 5 years assessment in 2016 and 10 year assessment in 2021. Patients with an aSAH in 2012 will have their 5 year assessment in 2017 and 10 year assessment in 2022 | Test of working memory |
| Mini Mental Status Examination (MMSE-NR3) | Patients with an aSAH in 2011 will have their 5 years assessment in 2016 and 10 year assessment in 2021. Patients with an aSAH in 2012 will have their 5 year assessment in 2017 and 10 year assessment in 2022 | Test |
| Breif Visual Memory Test | Patients with an aSAH in 2011 will have their 5 years assessment in 2016 and 10 year assessment in 2021. Patients with an aSAH in 2012 will have their 5 year assessment in 2017 and 10 year assessment in 2022 | Test of visual memory |
| Grooved Pegboard | Patients with an aSAH in 2011 will have their 5 years assessment in 2016 and 10 year assessment in 2021. Patients with an aSAH in 2012 will have their 5 year assessment in 2017 and 10 year assessment in 2022 | Test of motor skills |
| Color-Word interference test, Delis-Kaplan Test of Executive Function System | Patients with an aSAH in 2011 will have their 5 years assessment in 2016 and 10 year assessment in 2021. Patients with an aSAH in 2012 will have their 5 year assessment in 2017 and 10 year assessment in 2022 | Test of executive functions |
Countries
Norway
Outcome results
None listed